logo
Sudden selloff shakes US bond market

Sudden selloff shakes US bond market

Yahoo08-04-2025

SINGAPORE (Reuters) - U.S. Treasuries extended a sharp retreat on Tuesday as investors were having to sell bonds to cover losses in other assets and scrambled to unwind expectations for deep U.S. rate cuts, in the latest unsettling sign of possible stress in financial markets.
Monday's range for the benchmark 10-year yield was one of the largest in the past two decades while expectations evaporated that the Federal Reserve would start cutting interest rates within weeks to offset the economic pain caused by huge U.S. import tariffs.
Ten-year yields shot from an overnight low of 3.87% to touch 4.216% in the Asian day. Market participants said the scale of moves and uncertainty in Fed funds futures trade was unprecedented, as pricing for 130 basis points of U.S. rate cuts this year collapsed to 92 bps in a matter of hours.
Monday's 35-basis-point yield range was the eighth-largest on Tradeweb data stretching back 25 years.
It was not clear what flipped the switch from buying to selling, but the sudden turnaround pointed to pressure on stock markets and sentiment as markets lurch towards an April 9 deadline for U.S. tariffs. The S&P 500 has lost 10.7% in three sessions.
"What do you sell if you need to meet margin calls or liquidity? Treasuries and gold," said Martin Whetton, head of financial markets strategy at Westpac in Sydney.
Buyers were so scarce that the selling pushed bond yields out of line with swaps and sharply widened a usually steady spread between the two.
At the 10-year tenor the gap has shot to more than 50 basis points, the largest on record, while the speed of the move in the past few days has also been record-breaking.
"It just is a further validation of the theory that there's less physical buying of Treasuries," said Andrew Lilley, chief interest rates strategist at Sydney-based investment bank Barrenjoey.
"There's a period of time in any market blow up, where you are not even attempting to think through the implications. You are simply liquidating all your risk."
Lilley said markets may also be starting to come to terms with a changed trade outlook that could reduce foreign trade surpluses and international flows into the Treasury market, while others said markets were simply unstable.
"There's a conspicuous lack of clarity," said Vishnu Varathan, head of macro research for Asia outside of Japan at Mizuho in Singapore.
Two-year yields rose 7 basis points overnight and inched up to 3.796% in the Asia session.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

JPMorgan lifts yuan forecast on easing tariff risks, de-dollarisation trend
JPMorgan lifts yuan forecast on easing tariff risks, de-dollarisation trend

Yahoo

time17 minutes ago

  • Yahoo

JPMorgan lifts yuan forecast on easing tariff risks, de-dollarisation trend

LONDON (Reuters) -JPMorgan lifted its end-of-year forecast for China's onshore yuan spot price on Wednesday, citing moderating risks around the U.S. trade war and a broader global theme of so-called de-dollarisation. The U.S. investment bank said it was revising its dollar/yuan target to 7.15 yuan per dollar from 7.30, adding that it also expected a "gentle downtrend" to 7.10 by the middle of next year. The dollar was steady against the yuan at 7.1875 in European trading after U.S. and Chinese negotiators said they had agreed on a framework to get their countries' trade truce back on track following two days of talks in London. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company
Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company

Yahoo

time31 minutes ago

  • Yahoo

Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company

UPPSALA, SE / / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, has signed a new Master Service Agreement (MSA) - along with an initial Work Order of ~800 kSEK - with a Tier-1 US-based biopharmaceutical company. The new customer, a global leader in oncology drug development, becomes the fifth Tier-1 US biopharma company to join Biovica's Pharma Services customer base. The agreement covers testing of Phase 1 clinical trial samples in support of the development of next-generation CDK4/6 inhibitors and is a pilot study with DiviTum® TKa. " This marks a milestone in our growing customer base, highlighting the increasing relevance of Biovica's TKa biomarker assay in advanced cancer therapy development. It demonstrates the strong and growing recognition of the value our assay brings to the development of next-generation oncology treatments that ultimately benefit cancer patients. ," said Anders Rylander, CEO of Biovica. Contact Anders Rylander, CEOPhone: +46 76 666 16 47E-mail: Anders Morén, CFOPhone: +46 73 125 92 46E-mail: Biovica - Treatment decisions with greater confidence Biovica develops and commercializes blood-based biomarker assays that help oncologists monitor cancer progression. Biovica's assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker in the bloodstream. The assay has demonstrated its ability to provide insight to therapy effectiveness in several clinical trials. The first application for the DiviTum® TKa test is treatment monitoring of patients with metastatic breast cancer. Biovica's vision is: "Improved care for cancer patients." Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum® TKa has received FDA 510(k) clearance in the US and is CE-marked in the EU. Biovica's shares are traded on the Nasdaq First North Premier Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser. For more information, please visit: Attachments Biovica signs agreement with fifth Tier-1 US biopharma company SOURCE: Biovica International View the original press release on ACCESS Newswire Sign in to access your portfolio

Qantas is pulling the plug on Jetstar Asia — and 500 jobs
Qantas is pulling the plug on Jetstar Asia — and 500 jobs

Business Insider

time32 minutes ago

  • Business Insider

Qantas is pulling the plug on Jetstar Asia — and 500 jobs

Qantas is shutting down Jetstar Asia, its Singapore-based budget carrier, blaming rising operating costs and a crowded market. The budget airline will cease operations on July 31 after more than two decades. Jetstar Asia will continue flights until then on a "progressively reduced schedule," Qantas said in a statement on Wednesday. "Despite delivering exceptional customer service and operational reliability, Jetstar Asia has been impacted by rising supplier costs, high airport fees, and intensified competition in the region," the Australian company said. Jetstar Asia flies 16 routes from Singapore to destinations in Malaysia, Thailand, Indonesia, Japan, the Philippines, China, Sri Lanka, and Australia. Jetstar operations in Australia, New Zealand and Japan will not be affected. Customers booked on canceled flights will be offered full refunds, and Qantas will try to move them to other airlines where possible. The shutdown will also result in the loss of more than 500 jobs, a Jetstar Asia spokesperson told Business Insider. Affected employees will be given redundancy benefits and assistance with other roles within Qantas and other airlines. Qantas added that 13 Jetstar Asia Airbus A320 aircraft will be progressively redirected to Australia and New Zealand. Qantas did not immediately respond to a request for comment. Competition among budget carriers in Southeast Asia was "brutal," Alan Tan, a professor specializing in aviation law at the National University of Singapore's Law School, told Business Insider. "The departure is a great loss from the viewpoint of price and service competition for travellers," he said. Virgin Australia IPO The closure comes on the same day that Virgin Australia announced its intention to list on the stock market in Sydney on June 24. The shares will be priced at A$2.90, raising A$685 million and valuing the company at A$2.3 billion. The IPO will allow some existing investors, including Bain Capital, Qatar Airways Group, and the Virgin Group, to realize part of their holdings. Investors participating in the offer are expected to hold about 30% of shares on issue, with the remainder being held by existing investors. Virgin carries about 20 million passengers a year on more than 100 aircraft. It operates 76 routes to 38 destinations across its domestic and short-haul international airline business. From next week it will start long-haul international services between Australia and Doha in partnership with Qatar Airways, which has a 25% stake in Virgin. Budget model is 'dead' United Airlines CEO Scott Kirby earlier this month criticized the budget airline model and called it "crappy." He told the "Future of Everything" event that the low-cost carrier model was "dead." "The model was screw the customer," he said. "It was like trick people, get them to buy, and get them to come, and then charge them a whole bunch of fees that they aren't expecting … disclosures buried in legalese," he continued. "Their problem is they got big enough that they needed repeat customers. They don't get them." His comments came the same day that United announced a new partnership with JetBlue, which some consider to be a budget carrier.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store